ArticleOncology research2023

Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay.

Hongyuan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.